TREA

90477979 - BIOMEA

Follow

Information

  • Trademark
  • 90477979
  • Serial Number
    90477979
  • Filing Date
    January 20, 2021
    3 years ago
  • Transaction Date
    August 13, 2024
    4 months ago
  • Status Date
    August 13, 2024
    4 months ago
  • Published for Opposition Date
    March 08, 2022
    2 years ago
  • Location Date
    August 30, 2022
    2 years ago
  • Status Code
    733
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    ALAO, OREOLUWA
  • Attorney Docket Number
    122787.00058
    Attorney Name
    Philip R. Zender
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BIOMEA
Case File Statements
  • GS0051: Adjuvants for medical purposes; Anti-cancer preparations; Anti-sarcoma preparations; Cellular function activating agents for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and metabolic diseases; Chemotherapeutics; Cytostatics for pharmaceutical purposes; Diagnostic preparations for medical purposes; Medical preparations for the treatment of cancer and metabolic diseases; Medicinal infusions for treating cancer and metabolic diseases; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for cancer and metabolic diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of cancer and metabolic diseases; Pharmaceutical preparations for the treatment and prevention of cancer and metabolic diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer and metabolic diseases; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for cancer and metabolic diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, elixirs for the treatment of cancer and metabolic diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer and metabolic diseases; Tumor suppressing agents
  • GS0421: Biotechnology research; Development of new technology for others in the field of cancer and metabolic diseases; Development of pharmaceutical preparations and medicines; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and metabolic diseases; Testing of pharmaceuticals
Case File Event Statements
  • 6/11/2021 - 3 years ago
    3 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/11/2021 - 3 years ago
    4 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/7/2021 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/23/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/21/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/11/2021 - 3 years ago
    5 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/15/2021 - 3 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/15/2021 - 3 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/15/2021 - 3 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/7/2022 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/8/2022 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/7/2022 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/1/2022 - 2 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/8/2022 - 2 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/16/2022 - 2 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/8/2022 - 2 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/10/2022 - 2 years ago
    18 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 4/7/2022 - 2 years ago
    17 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 6/10/2022 - 2 years ago
    19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/10/2022 - 2 years ago
    20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/10/2022 - 2 years ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/10/2022 - 2 years ago
    22 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/17/2022 - 2 years ago
    23 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 8/30/2022 - 2 years ago
    24 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/16/2022 - 2 years ago
    25 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/16/2022 - 2 years ago
    26 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/16/2022 - 2 years ago
    27 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 8/11/2023 - a year ago
    29 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/20/2022 - 2 years ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/13/2024 - 4 months ago
    37 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/13/2024 - 4 months ago
    40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/13/2024 - 4 months ago
    38 - SOU EXTENSION 4 FILED Type: EXT4
  • 8/13/2024 - 4 months ago
    39 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 1/11/2024 - 12 months ago
    36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/11/2023 - a year ago
    30 - SOU EXTENSION 2 FILED Type: EXT2
  • 8/11/2023 - a year ago
    31 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 8/15/2023 - a year ago
    32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/9/2024 - 12 months ago
    33 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/9/2024 - 12 months ago
    34 - SOU EXTENSION 3 FILED Type: EXT3
  • 1/9/2024 - 12 months ago
    35 - SOU EXTENSION 3 GRANTED Type: EX3G